Selcuk Dental Journal, vol.6, no.3, pp.261-270, 2019 (Peer-Reviewed Journal)
ABSTRACT
Effect of anatomical location (mandible vs maxilla) of dental
implants on the BMP-2, BMP-7, sRANKL and OPG levels in
peri-implant crevicular fluid during osseointegration. A pilot
study
Background: The aim of this study was to investigate levels of bone
morphogenetic protein-2 (BMP-2), BMP-7, soluble receptor activator
of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) in
the peri-implant crevicular fluid (PICF) of implants placed in both
maxilla and mandible during the osseointegration period.
Materials and Methods: Thirty-three patients (17 females and 16
males; mean age 47.03±11.23 years) were included in this study. A
total of 33 implants were placed in both of maxilla (Group 1/n=18)
and mandible (group 2/n=15). Peri-implant crevicular fluid (PICF)
samples, modified plaque index (MPI), gingival index (GI) and
probing depth (PD) measurements were obtained at 1 and 3
months after surgery. PICF levels of BMP-2/-7, sRANKL and OPG
were analyzed by ELISA.
Results: No complications were observed during the healing
period. No significant differences were observed in the PICF levels
of sRANKL, OPG, BMP-2 and BMP-7 and evaluated clinical
parameters between groups at any time point (p>0.05). While PICF
volume of group 2 was greater than group 1 at first month, PICF
volume of group 1 was greater than group 2 at 3 months (p<0.05).
There was a positive correlation between sRANKL levels and PICF
volume (p<0.05) and a strong correlation between BMP-2 and
BMP-7 (p<0.01).
Conclusion: The results of this pilot study didn’t show any
significant difference in PICF levels of BMP-2, BMP-7, sRANKL, and
OPG in terms of anatomic location of dental implants. Further welldesigned studies should be carried out to evaluate the relationship
between bone related biomarkers and anatomic location of dental
implants.
KEYWORDS
Bone morphogenetic proteins, dental implant, osteoprotegerin,
receptor activator of nuclear factor-kappa B